@MisterInversor MisterInversor
Spanish-language perma-bull preaching an AI-plus-biology-plus-Bitcoin secular wealth revolution
Original retail-facing analyst running a high-conviction, lo
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY. · Analyst brief as of 2026-06-22.
Across their last 20 scored bets: 30% hit rate, -0.48% mean alpha, trader score -0.57. Their last-14d mentions, direction-adjusted, have moved +4.4% since posting (mean over 164 mentions with price data).
MisterInversor is concentrated in long-duration growth holdings, led by HIMS as largest position, DUOL as third-largest, and ASST as fourth-largest. His distinctive read is that healthcare/longevity, personalized education, Bitcoin treasury exposure, AI compute power scarcity, and Tesla physical AI are early multi-year compounding themes being mispriced by late-arriving analysts. Late-window posting became especially concentrated in HIMS and DUOL thesis reinforcement, with no clear bearish flip.
No clear bearish flip appears in the window; the author remains consistently bullish across HIMS, DUOL, ASST, TSLA and IREN. Posting late in the week shifts heavily toward HIMS and DUOL thesis reinforcement, including HIMS platform catalysts and repeated DUOL valuation/price-target promotion. Pump-risk is highest in the single-name DUOL theme and in the repeated HIMS largest-position narrative.
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-07-03 | HIMS | @MisterInversor | +0.75 | Discloses HIMS is the author's largest position for the second half. | — | tweet ↗ |
| 2026-07-02 | DUOL | @MisterInversor | +0.65 | Lists stocks the author believes are very undervalued today. | — | tweet ↗ |
| 2026-07-02 | IREN | @MisterInversor | +0.65 | Lists stocks the author believes are very undervalued today. | — | tweet ↗ |
| 2026-07-02 | HIMS | @MisterInversor | +0.65 | Lists stocks the author believes are very undervalued today. | — | tweet ↗ |
| 2026-07-02 | ASST | @MisterInversor | +0.65 | Lists stocks the author believes are very undervalued today. | — | tweet ↗ |
| 2026-07-02 | DUOL | @MisterInversor | +0.60 | Expects DAU and MAU reacceleration from Q2 results. | — | tweet ↗ |
| 2026-07-02 | HIMS | @MisterInversor | +0.55 | Says only patient and brave holders will go to Valhalla in HIMS. | — | tweet ↗ |
| 2026-07-02 | CRSP | @MisterInversor | +0.30 | Links latest thesis update for CRSP. | — | tweet ↗ |
| 2026-07-02 | CRSP | @MisterInversor | +0.65 | Says CRSP shows strong execution and development; thesis is powerful if it continues. | — | tweet ↗ |
| 2026-07-02 | CRSP | @MisterInversor | +0.50 | FDA approves expansion of CRSP treatment for children. | — | tweet ↗ |
| 2026-07-02 | DUOL | @MisterInversor | +0.35 | Anecdotally sees more people using Duolingo. | — | tweet ↗ |
| 2026-07-02 | IBRX | @MisterInversor | +0.50 | Says biotech next 5 years will be wild, with TEM and CRSP above $60 and IBRX near $10. | — | tweet ↗ |
| 2026-07-02 | TEM | @MisterInversor | +0.55 | Says biotech next 5 years will be wild, with TEM and CRSP above $60 and IBRX near $10. | — | tweet ↗ |
| 2026-07-02 | CRSP | @MisterInversor | +0.55 | Says biotech next 5 years will be wild, with TEM and CRSP above $60 and IBRX near $10. | — | tweet ↗ |
| 2026-07-02 | HIMS | @MisterInversor | +0.70 | Bullish on health/biotech firms due to expected health issues over coming months/years. | — | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.